(Q28478539)

English

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation

scientific article

In more languages

Statements

scholarly article

0 references

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation (English)

0 references

1 reference

based on heuristic

inferred from title

phosphorylation

1 reference

based on heuristic

inferred from title

object named as

Miguel López

9

0 references

Ruben Nogueiras

object named as

Rubén Nogueiras

5

0 references

Antonio Vidal-Puig

object named as

Antonio Vidal-Puig

7

0 references

8

object named as

Vidar M Steen

0 references

author name string

Johan Fernø

1

0 references

Luis Varela

2

0 references

Silje Skrede

3

0 references

María Jesús Vázquez

4

0 references

Carlos Diéguez

6

0 references

language of work or name

0 references

publication date

2011

0 references

0 references

6

0 references

6

0 references

e20571

0 references

copyright license

Creative Commons Attribution 4.0 International

13 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3113797/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

19 March 2017

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

19 March 2017

The AMP-activated protein kinase cascade--a unifying system for energy control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

19 March 2017

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

19 March 2017

A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

19 March 2017

Central nervous system control of food intake and body weight

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

7 April 2017

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

7 April 2017

Ghrelin and lipid metabolism: key partners in energy balance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Preclinical models of antipsychotic drug-induced metabolic side effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

AMPK: a metabolic gauge regulating whole-body energy homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Peripheral tissue-brain interactions in the regulation of food intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

Hypothalamic malonyl-CoA as a mediator of feeding behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

29 September 2017

UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

2 June 2018

Obesity as a risk factor for antipsychotic noncompliance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

A parametric analysis of olanzapine-induced weight gain in female rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Characterization of olanzapine-induced weight gain in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyper

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

A model for antipsychotic-induced obesity in the male rat.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Influence of ghrelin and growth hormone deficiency on AMP-activated protein kinase and hypothalamic lipid metabolism.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Antipsychotic drug-induced weight gain: development of an animal model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020571

21 January 2018

Chronic administration of olanzapine affects Behavioral Satiety Sequence and feeding behavior in female mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

27 November 2018

The AMPK-malonyl-CoA-CPT1 axis in the control of hypothalamic neuronal function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

27 November 2018

An animal model of antipsychotic-induced weight gain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3113797

27 November 2018

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21695181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adiposity and eating behaviors in patients under second generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21695181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0020571

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2011PLoSO...620571F

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28478539&oldid=1967129997"